Skip to main content
Premium Trial:

Request an Annual Quote

Cosmo Bio Distributing DNA2.0 Products in Japan

NEW YORK (GenomeWeb News) – DNA2.0 on Monday announced a deal with Cosmo Bio to distribute DNA2.0's complete line of bioengineering products.

Financial and other terms of the deal were not disclosed.

Customers can access DNA2.0's products directly, but the deal with Cosmo Bio provides customers in Japan added flexibility and time savings, as well as service and support, DNA2.0 said.

Based in Menlo Park, Calif., is a synthetic biology firm and the largest provider of synthetic genes in the US, it said. Cosmo Bio, based in Tokyo, provides life science products to researchers in Japan and elsewhere.

Filed under

The Scan

Prenetics to Go Public Through SPAC

Prenetics, a Hong Kong-based genomic and diagnostic company, is going public through a SPAC merger, according to 360Dx.

Nature Papers Examine Genomes of Centenarians, Transcription-Coupled DNA Repair

In Nature this week: analysis of centenarian genomes uncovers longevity-linked variants, and more.

Removal Inquiry

The Wall Street Journal reports that US lawmakers are seeking additional information about the request to remove SARS-CoV-2 sequence data from a database run by the National Institutes of Health.

Likely to End in Spring

Free lateral flow testing for SARS-CoV-2 may end in the UK by next spring, the head of Innova Medical Group says, according to the Financial Times.